Johnson & Johnson promises 2021 profit jump, vaccine data 'soon'
Johnson & Johnson on Tuesday forecast 2021 profit above Wall Street estimates and promised data from its widely watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.
The company had previously signaled that it expected to deliver data on the trial before the end of January, at a time when global hopes of defeating the virus are riding on securing adequate supplies of multiple vaccines.
Johnson & Johnson, which runs a large medical device business in addition to its pharmaceuticals unit, forecast 2021 adjusted profit of between $9.40 and $9.60 per share, compared with analysts' estimates of $8.99 per share, according to IBES data from Refinitiv.
The company's fourth-quarter profit fell 56.7% to $1.74 billion. The company reported that it had recorded litigation expenses of $2.9 billion in the fourth quarter.
J&J faces a litany of lawsuits over its marketing of opioids, its pelvic meshes and body powders.
The company's fourth-quarter sales rose to $22.48 billion from $20.75 billion, helped by higher demand for cancer drugs.

India says OPEC+ decision to extend oil output cuts will hit economic recovery

Gender inequality has cost world USD 70 trillion since 1990, finds report

Gold price falls further to ₹44,344, sets retail buyers on buying spree
- Retail buyers continued to purchase gold in India as prices declined to a near one-year low.

Sebi lays guidelines on votes cast by mutual funds

India's forex reserves increase by USD 689 million to USD 584.55 billion: RBI

OPEC ignores India's call; Saudi asks New Delhi to use cheap oil bought last yr

Tax cut should be joint call of Centre, states: Sitharaman on high fuel prices

Germany to pay nuclear operators 2.4 billion euros for plant closures

SoftBank strategy chief Katsunori Sago plans exit after just three Years

Utkarsh Small Finance Bank files for IPO, plans to raise ₹13,500 million

Microsoft’s $10 billion Pentagon deal at risk amid Amazon fight

Sensex falls 440 pts to end at 50,405; Nifty ends session in red at 14,938 pts
- Sensex falls 440 pts to end at 50,405; Nifty ends session in red at 14,938 points

Amazon's 'Tandav' row puts Bollywood, global streaming giants on edge
- Companies like Amazon's Prime Video and Netflix are inspecting planned shows and scripts, with some even deleting scenes that could be controversial, five Bollywood directors and producers, and two industry sources said.

Asian LNG prices edge higher on Indian, Chinese demand
